QuantRx Biomedical Corporation Provides Corpor... ( PORTLAND Ore. July 14 2011 /- QuantRx...)

QuantRx Biomedical Corporation Provides Corporate Update

Date:7/14/2011

PORTLAND, Ore., July 14, 2011 /PRNewswire/ -- QuantRx® Biomedical Corporation (OTCQB:QTXB), an emerging leader in the development and commercialization of innovative diagnostic products based on its patented technology platforms, is pleased to announce that following the successful resolution and full settlement of all matters related to the QN Joint Venture as disclosed in a Form 8-K filed with the SEC on July 8, 2011, the Company is currently implementing a go to market strategy for its market ready over-the-counter (OTC) healthcare products.

Further, the Company plans to initiate a clinical study to confirm an innovative, and potentially practice changing, approach to fetal genomic diagnostics using its patented PadKit technology. These clinical investigations will be done in collaboration with GMSBIOTECH, with initial data anticipated to be generated prior to year end.

Dr. Shalom Hirschman, Chairman and CEO, stated, "The company is developing strategic plans to bring products to market as quickly as possible. Our OTC pads for daily feminine hygiene and intergluteal pads for the temporary relief of hemorrhoids will be the focus of the initial commercialization effort."

Further, Dr, William Fleming, Chief Scientific Officer, stated, "We are committed to building shareholder value by capitalizing on our innovative patented diagnostic technologies, particularly our genomic-based diagnostic technology targeting the monitoring of recurring cancers and serious fetal genomic disease and health conditions."

About QuantRx Biomedical

QuantRx Biomedical Corporation (OTCQB: QTXB) is focused on the development and commercialization of innovative over-the-counter and genomic products for advanced diagnosis of serious disease and health conditions. With synergistic expertise in the discovery of diagnostic platforms leveraging a vast portfolio of intellectual property, QuantRx's mission is to introduce products for use by its
'/>"/>

SOURCE QuantRx Biomedical
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3
Related medicine technology :

1. QuantRx Biomedical Settles Suit: Launches New PAD-Based Genomic Diagnostic Products
2. Dr. Napoleone Ferrara Wins 2011 Dr. Paul Janssen Award for Biomedical Research
3. Saladax Biomedical, Inc. Completes $9 Million Debt Financing With GE Capital
4. NCIIA Funds University Biomedical Engineering Teams at BMEidea Awards
5. Saladax Biomedical, Inc. Announces Pacific Rim Commercialization Team in Australia and China
6. Dainippon Sumitomo Pharma Co., Ltd. and Boston Biomedical, Inc. Enter Strategic Partnership on Anti-Cancer Drugs Targeting Cancer Stem Cells
7. R. Lindholm Named to Crux Biomedical Board
8. FCC Approval of Finite Element Method for Biomedical Transmitters Puts ANSYS Software in the Spotlight
9. Plexus Biomedical Inc. Gains FDA Approval of the First Medical Device to Help Prevent External Hemorrhoids During Vaginal Childbirth
10. Dr. Paul Janssen Award for Biomedical Research Issues Call for Nominations
11. BioMedical Enterprises, Inc. (BME) Introduces the HammerLock™ Shape Memory Device for Hammertoes.

Post Your Comments:

(Date:5/21/2013)... WESTBURY, N.Y. , May 21, 2013 Vasomedical, Inc. ... specializing in the design, manufacture and sale of medical devices ... today that Dr. Jun Ma , President ... Annual Marcum LLP MicroCap Conference on Thursday, May 30, 2013 ... Grand Hyatt Hotel. The Company,s presentation is ...

(Date:5/21/2013)... , May 21, 2013 ... report is available in its catalogue: ... and Technologies for Optical Coherence Tomography (OCT) ... STUDY OBJECTIVES ... study is to offer synopsis of the ...

(Date:5/21/2013)... Fla. , May 21, 2013 Janssen ... safety results from the global Phase 3 PROMISE ... inhibitor simeprevir (TMC435) led to sustained virologic response ... in 79 percent of treatment-experienced genotype 1 chronic ... including all stages of liver fibrosis, when administered ...

[0] Vasomedical, Inc. To Present At The Second Annual Marcum LLP MicroCap Conference [0] Global Markets and Technologies for Optical Coherence Tomography (OCT)[0] Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients

... Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN ) will ... Conference on Monday, September 20, 2010. The presentation is ... be accessed through the Company,s web site, www.regeneron.com ... of the presentation will be available after the live ...

... Shield Healthcare, a leading provider of medical supplies for ... annual story contest on "What Makes Caregiving Rewarding?" designed ... home healthcare professionals, featuring celebrity contest judge, Sandra Mitchell ... caregiving is a demanding job. A significant number of ...

Cached Medicine Technology:Shield Healthcare Announces 10th Annual Caregiver Story Contest 2

Regeneron Announces Presentation at the UBS Global Life Sciences Conference Shield Healthcare Announces 10th Annual Caregiver Story Contest

(Date:5/21/2013)... ROCHESTER, Minn. Positively charged gold nanoparticles are ... manage to avoid nanoparticle toxicity. Mayo Clinic researchers ... the nanoparticles effective against ovarian cancer cells. The ... of the Journal of Biological Chemistry ., ... ovarian cancer cells by preventing the cell death ...

(Date:5/21/2013)... Residents in St. Petersburg, FL have a ... Dr. David Sherberg, DMD, has joined Coast Dental Pasadena, ... provides preventive, restorative and cosmetic dentistry to patients age ... provide a wide variety of services including ... crowns, bridges, dentures, dental implant restorations, veneers, laser therapy, ...

(Date:5/21/2013)... (PRWEB) May 21, 2013 TheBeautyPlace.com helps ... day. TheBeautyPlace.com features a Big Day Kit including all ... might need to shine on their Wedding Day. , ... to smile about on their Wedding Day. Flowers blooming ... the start of wedding season. From Memorial Day to ...

(Date:5/21/2013)... St. Louis, MO (PRWEB) May 21, 2013 ... the first insulin pump she used with her patients in the ... the “big blue brick.” For the most part, it could only ... greatly in the 30 years since then, and the advantages are ... device worn on the outside of the body, often on a ...

(Date:5/21/2013)... The producers of Net Worth Business TV ... Ontario, Canada. The area is famous for its natural beauty ... It is located an hour from Toronto and is easily ... the Kawartha Hills, home to several towns, villages and hamlets ... area. Residents and visitors to this region will be able ...

Breaking Medicine News(10 mins):Health News:Mayo Clinic: How gold nanoparticles can help fight ovarian cancer 2 Health News:Coast Dental Pasadena Welcomes Dr. David Sherberg 2 Health News:Coast Dental Pasadena Welcomes Dr. David Sherberg 3 Health News:TheBeautyPlace.com Previews their Emergency Big Day Kit to Get Brides Ready For this Upcoming Wedding Season 2 Health News:TheBeautyPlace.com Previews their Emergency Big Day Kit to Get Brides Ready For this Upcoming Wedding Season 3 Health News:Kaufman Shows People With Diabetes How to Use New Technology to Improve Their Lives 2 Health News:Kaufman Shows People With Diabetes How to Use New Technology to Improve Their Lives 3 Health News:Kaufman Shows People With Diabetes How to Use New Technology to Improve Their Lives 4 Health News:Net Worth Business TV Announces May Air Dates for Peterborough, Ontario 2

[0] Mayo Clinic: How gold nanoparticles can help fight ovarian cancer [0] Coast Dental Pasadena Welcomes Dr. David Sherberg [0] TheBeautyPlace.com Previews their Emergency Big Day Kit to Get Brides Ready For this Upcoming Wedding Season [0] Kaufman Shows People With Diabetes How to Use New Technology to Improve Their Lives [0] Net Worth Business TV Announces May Air Dates for Peterborough, Ontario

... Society, the largest non-government, not-for-profit funding source of cancer research ... training grants totaling more than $52.6 million in the first ... are new and 18 are renewals of previous grants. All ... The American Cancer Societys Research and Training Program has funded ...

... III development of ,GI-friendly, NSAIDs for mild ... Horizon Therapeutics, Inc. is pleased to announce that ... showcase Horizon,s ... including its recent completion of Series C financing, and ...

... Calcium Brand Enriches Consumer Care Division,s Key ... Nutritionals Product Portfolio, ... that its Consumer Care Division has received regulatory,approvals necessary to ... United States. The U.S. portion of the,transaction with Mission Pharmacal ...

... Oct. 5 Eli Lilly and Company,announced today ... the U.S. Food,and Drug Administration (FDA), the company ... fluoxetine HCl) U.S. product,labels. This new labeling information ... . The updates reflect recently completed pooled ...

... (CTI),(Nasdaq: CTIC ; MTAX) management will present at ... The conference will be held October 9-11, 2007, at ... Wednesday, October 10 at 12:45 p.m.,(PT). The conference will ... the presentation. The webcast can be accessed at, http://www.cticseattle.com ...

... SAN FRANCISCO, Calif., Oct. 5 Anesiva,Inc. (Nasdaq: ... company,s,chief executive officer, will present at the Biotechnology Industry,Organization,s ... am PDT in San Francisco. To access the ... http://www.anesiva.com and go to the Investors page, ...

Cached Medicine News:Health News:American Cancer Society awards research grants to 109 investigators at 77 institutions nationwide 2 Health News:American Cancer Society awards research grants to 109 investigators at 77 institutions nationwide 3 Health News:Horizon Therapeutics, Inc. Scheduled to Present at Upcoming BioPartnering Europe Meeting 2 Health News:Bayer HealthCare Cleared to Acquire Citracal(R) 2 Health News:Bayer HealthCare Cleared to Acquire Citracal(R) 3 Health News:Lilly Announces Updates to the Zyprexa and Symbyax U.S. Labels 2 Health News:Lilly Announces Updates to the Zyprexa and Symbyax U.S. Labels 3 Health News:Lilly Announces Updates to the Zyprexa and Symbyax U.S. Labels 4 Health News:Lilly Announces Updates to the Zyprexa and Symbyax U.S. Labels 5 Health News:Lilly Announces Updates to the Zyprexa and Symbyax U.S. Labels 6 Health News:Lilly Announces Updates to the Zyprexa and Symbyax U.S. Labels 7 Health News:Lilly Announces Updates to the Zyprexa and Symbyax U.S. Labels 8

American Cancer Society awards research grants to 109 investigators at 77 institutions nationwide Horizon Therapeutics, Inc. Scheduled to Present at Upcoming BioPartnering Europe Meeting Bayer HealthCare Cleared to Acquire Citracal(R)Lilly Announces Updates to the Zyprexa and Symbyax U.S. Labels Cell Therapeutics, Inc. (CTI) to Present at BIO Investor Forum Anesiva to Present at BIO InvestorForum on October 11, 2007

The ImmunoWELL TPO IgG Quantitative Test is a quantitative enzyme immunoassay (EIA) for screening and detection of autoantibodies against human thyroid peroxidase (microsome) in serum and is used as ...

... The ImmunoDOT Autoimmunity Screening Panel 4 ... for screening and detection of autoantibodies ... (SS-A, SS-B, RNP/Sm, and Sm) in ... aid in the diagnosis of systemic ...

The 8500 is an extremely reliable portable pulse oximeter, requiring no periodic maintenance or calibration....

Rad-5 signal extraction pulse oximeter™...

Medicine Products:

ImmunoWELL TPO IgG Quantitative Test ImmunoDOT Autoimmunity Screening Panel 4 Pulse Oximeter Model: THS 8500 Rad-5 signal extraction pulse oximeter™